CORRIGENDUM

No authors listed

Published Erratum

No authors listed. Diabetes Obes Metab. 2019 Jan.

. 2019 Jan;21(1):203.

doi: 10.1111/dom.13563. Epub 2018 Nov 8.

No abstract available

Erratum for

Efficacy and safety of dapagliflozin in patients with type 2 diabetes and moderate renal impairment (chronic kidney disease stage 3A): The DERIVE Study.
Fioretto P, Del Prato S, Buse JB, Goldenberg R, Giorgino F, Reyner D, Langkilde AM, Sjöström CD, Sartipy P; DERIVE Study Investigators. Fioretto P, et al. Diabetes Obes Metab. 2018 Nov;20(11):2532-2540. doi: 10.1111/dom.13413. Epub 2018 Jul 10. Diabetes Obes Metab. 2018. PMID: 29888547 Free PMC article. Clinical Trial.